Atlas Trials

A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist

Clinical trial NCT04294147 · COMPLETED

Trial details

NCT number
NCT04294147
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Migraine
Start date
2020-10-06
Primary completion
2021-03-05
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.